Hyku Biosciences

Hyku Biosciences is a biotechnology company located in the Greater Boston area, dedicated to building a leading covalent drug discovery platform to inhibit disease targets that are difficult to address with traditional methods. Hyku's drug discovery engine is based on its proprietary platform technology, which can identify binding pockets based on histidine, tyrosine, and lysine, providing rational drug design for therapeutic development. The platform pioneered by Hyku has the potential to fundamentally expand the scope of small-molecule drug discovery, significantly increase the druggability of many target categories, and bring substantial therapeutic benefits to patients through new drugs.